Page 8 - விண்ட்லாஸ் பயோடெக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Windlas, Devyani, Exxaro, Krsnaa Diagnostics: Here s how the 4 IPOs fared on opening day
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.
Zomato incorporates subsidiary Zomato Payments to offer payment gateway services
india.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from india.com Daily Mail and Mail on Sunday newspapers.
Windlas Biotech IPO opens today: Should you subscribe? Brokerages weigh in
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.
Windlas Biotech s financials a tad weaker than peers but prospects strong
Consequently, Cadila Healthcare, which had picked up a stake in the business, exited swiftly at a loss. The company now caters to Indian as well as non-US export markets.
Synopsis
WBL is rolling out a Rs 402-crore IPO comprising Rs 165 crore of fresh issue and an offer-for-sale in which one of the promoters is selling and the PE fund Tano India is offloading its entire 22% stake in WBL. From the IPO proceeds, Rs 50 crore is to be used for capex, Rs 48 crore for working capital and Rs 20 crore for debt repayment.
Windlas Biotech IPO: All You Need To Know
Aug 03 2021, 7:40 AM
August 03 2021, 7:36 AM
August 03 2021, 7:40 AM
Windlas Biotech Ltd. will launch its three-day initial public offering starting Aug. 4 as the contract manufacturer of pharmaceutical formulations looks to pare debt and expand capacity in a record year for Indian companies turning public.The company will sell shares at Rs 448-460 apiece seeking a market value of Rs 1,002.5 crore at its upper end of the price band. The Rs 401.5-crore initial share sale comprises a fresh issue of Rs 1.
Windlas Biotech Ltd. will launch its three-day initial public offering starting Aug. 4 as the contract manufacturer of pharmaceutical formulations looks to pare debt and expand capacity in a record year for Indian companies turning public.